RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes(Ghent University), Frank Speleman(Ghent University Hospital)
Cited by 47
Related Papers
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
|Cancer Letters|2015|50